When it comes to safeguarding cardiovascular health through Traditional Chinese Medicine (TCM), Tasly Health Products offers two formidable contenders: Tongluo Capsules and ICP (Innovative Cardiotonic Pill/Danshen Plus). Both have earned their stripes in the fight against heart disease, angina, and circulatory disorders, yet they approach the battle with distinctly different arsenals. If you've ever wondered which TCM formula aligns with your heart health needs, this comprehensive comparison will illuminate their shared missions and unique battle strategies.
The Common Ground: Where These Two TCM Titans Align
Despite their different formulations, Tongluo Capsules and ICP share several critical similarities that make them both valuable assets in cardiovascular care:
1. The Angina Assault Strategy
Both products specifically target angina pectoris—the chest pain that signals your heart isn't getting enough oxygen-rich blood. Clinical evidence suggests both formulations effectively reduce the frequency and severity of angina attacks, offering relief to those suffering from coronary heart disease (CHD) .
2. Blood Stasis Breakthrough
Rooted in TCM theory, both capsules excel at "activating blood circulation and removing blood stasis" (活血化瘀). This ancient concept translates to modern cardiovascular benefits: improving microcirculation, reducing blood viscosity, and preventing the dangerous clots that trigger heart attacks and strokes .
3. Post-Heart Attack Recovery
Both supplements position themselves as allies in recovery after acute myocardial infarction (heart attack). They aim to protect cardiac muscle, improve vascular function, and reduce complications following cardiovascular events .
4. The Microcirculation Mission
Each formula recognizes that heart health isn't just about major arteries—it's about the microscopic blood vessels (the "second heart") that nourish tissues. Both improve microcirculation, which is crucial for preventing diabetic complications and ensuring optimal organ perfusion .
5. Plaque Stabilization & Arterial Protection
Modern research indicates both formulations may help stabilize atherosclerotic plaques—the dangerous deposits that can rupture and cause catastrophic cardiovascular events. ICP specifically has demonstrated the ability to reduce carotid intima-media thickness (IMT), indicating plaque regression .
---
The Great Divide: Where These Warriors Diverge
This is where the comparison gets fascinating. While their end goals overlap, their methodologies, ingredients, and specific applications differ dramatically:
The Ingredient Philosophy: Insects vs. Botanicals
Feature Tongluo Capsules (Tongxinluo) ICP (Danshen Pills)
Primary Composition Insect-herbal hybrid: Ginseng, Leech (Hirudo), Scorpion, Centipede, Ground Beetle, Cicada Slough, Red Peony, Sandalwood, Borneol Pure botanical: Danshen (Salvia miltiorrhiza), Sanqi (Notoginseng), Borneol
Star Ingredients Hirudin-like compounds from leeches and scorpions (potent anticoagulants) Tanshinone IIA, Salvianolic acid B, Notoginsenosides
Formulation Approach Complex 12-ingredient matrix including animal products Streamlined 3-ingredient botanical concentrate
The Critical Distinction: Tongluo embraces zootherapy (medicinal use of animals)—specifically insects and invertebrates like leeches, scorpions, and centipedes. These creatures provide powerful anticoagulant compounds similar to hirudin. ICP, conversely, relies entirely on plant-based pharmacology, focusing on the extensively researched Danshen (Salvia miltiorrhiza) root combined with Sanqi (Panax notoginseng) .
Speed of Action: The Emergency Response Factor
ICP takes the crown for rapid intervention. Its innovative "dripping pill" formulation allows for sublingual administration—placing the pills under the tongue for direct absorption into the bloodstream. This bypasses the digestive system and first-pass liver metabolism, delivering relief in 3-8 minutes for acute angina attacks. In fact, 40.2% of patients experience immediate pain relief, with an overall effectiveness rate exceeding 88% .
Tongluo operates on a different timeline. While effective for angina, it's generally administered orally (2-4 capsules, 3 times daily) and functions more as a sustained therapeutic agent rather than an emergency rescue medication. Its strength lies in long-term collateral vessel protection and gradual plaque stabilization rather than instant symptom relief .
Scientific Validation & Clinical Pedigree
Both have impressive research portfolios, but with different highlights:
Tongluo's Claim to Fame:
- The landmark CTS-AMI trial (2023) published in JAMA demonstrated that Tongxinluo significantly improved 30-day and 1-year clinical outcomes in patients with acute ST-segment elevation myocardial infarction (STEMI) when used alongside standard treatments .
- This large-scale, randomized, double-blind, placebo-controlled trial enrolled 3,797 patients across 124 Chinese hospitals, showing a 36% relative risk reduction in major adverse cardiovascular events at 30 days .
ICP's Scientific Standing:
- Over 2 billion doses prescribed worldwide across 24 countries .
- Proven ability to shrink atherosclerotic plaques in carotid arteries—a feat previously thought impossible with natural interventions .
- Research from Keio University Medical School (Japan) confirming multi-target effects on microcirculation disturbances .
Target Audience & Best Applications
Choose Tongluo Capsules if you:
- Are recovering from heart surgery or acute myocardial infarction (shown to reduce surgical complications)
- Need comprehensive collateral vessel protection and long-term plaque stabilization
- Have diabetic microvascular complications (neuropathy, retinopathy)
- Are comfortable with insect-based TCM traditions (leech, scorpion, centipede components)
- Seek support for stroke recovery and cerebrovascular health
Choose ICP (Danshen Pills) if you:
- Experience acute angina attacks requiring rapid relief (sublingual option available)
- Prefer plant-based supplements without animal ingredients
- Need to lower blood lipids (cholesterol and triglycerides) specifically
- Want liver protection alongside cardiovascular support (shown to normalize liver function and repair impaired liver cells)
- Are managing metabolic syndrome or diabetic complications through improved microcirculation
- Seek a product with higher bioavailability and quicker absorption profiles
Safety Profiles & Considerations
Tongluo Considerations:
- Contains animal products (insects) that may cause gastrointestinal discomfort in some users
- Rare cases of gingival bleeding and increased partial thromboplastin time reported
- May not be suitable for those with insect allergies or cultural/religious restrictions regarding animal products
- Standard dosage: 2-4 capsules, 3 times daily (higher frequency than ICP)
ICP Considerations:
- Generally well-tolerated with "no side effects" reported in clinical documentation
- Not recommended for children under 12 or during pregnancy/breastfeeding (due to blood-activating properties)
- Lower dosage frequency: 2 capsules, 1-2 times daily
- Caution with high-cholesterol foods during usage (not due to interaction, but because cardiovascular patients should avoid these regardless)
---
The Verdict: Complementary Warriors, Not Competitors
Rather than viewing Tongluo Capsules and ICP as rivals, savvy practitioners and patients recognize them as complementary forces in cardiovascular wellness:
- ICP excels as the rapid-response agent—the botanical firefighter that extinguishes acute angina attacks while gradually cleaning arterial walls and improving microcirculation. Its plant-based composition makes it universally acceptable and its sublingual delivery system offers unique emergency utility.
- Tongluo stands as the intensive rehabilitation specialist—the insect-herbal complex that dives deep into collateral circulation, protects microvessels, and demonstrates remarkable efficacy in post-MI recovery and stroke rehabilitation. Its complex zootherapeutic formula offers benefits that pure botanicals cannot replicate.
The Strategic Approach: Many cardiovascular patients might actually benefit from both—using ICP for acute angina management and rapid microcirculatory support, while incorporating Tongluo for long-term vascular remodeling, post-event recovery, and comprehensive collateral protection.
However, never combine these without professional supervision. Both are potent blood-activating agents, and their combined anticoagulant effects could pose risks. Always consult with a TCM practitioner or cardiologist familiar with these formulations to determine the optimal strategy for your specific cardiovascular landscape.
In the ancient tradition of TCM, there is no single "best" remedy—only the right remedy for the right pattern. Whether you choose the insect-powered precision of Tongluo or the botanical speed of ICP, you're harnessing centuries of Chinese medical wisdom to protect your most vital organ.
References: This analysis draws from clinical studies including the CTS-AMI trial (JAMA 2023), Cochrane systematic reviews, research from Keio University Medical School, and product documentation from Tasly Health Products.
